Clicky

Fulgent Genetics, Inc.(FLGT)

Description: Fulgent Genetics, Inc. is a technology company. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. The Company has developed a technology platform that integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory processes. As of December 31, 2015, the Company's test menu includes approximately 18,000 single-gene tests and over 200 pre-established, multi-gene, disease-specific panels that collectively test for approximately 7,500 genetic conditions, including various cancers, cardiovascular diseases and neurological disorders. The Company's gene probes are specifically engineered to generate genetic data that is optimized for its software, which enables to rapidly incorporate new genes into its test menu, develop new panels of disease-specific tests and customize tests for its customers.


Keywords: Medicine Biotechnology Cancer Cardiovascular Disease Medical Test Neurological Disorders Genetics Molecular Diagnostics Medical Genetics Vascular Disease Algorithms Urological Disorders Applied Genetics Genetic Testing Qiagen Alternatives To Animal Testing Adaptive Learning

Home Page: www.fulgentgenetics.com

FLGT Technical Analysis

4978 Santa Anita Avenue
Temple City, CA 91780
United States
Phone: 626 350 0537


Officers

Name Title
Mr. Ming Hsieh Chairman & CEO
Mr. Jian Xie COO & Pres
Mr. Paul Kim Chief Financial Officer
Dr. Han Lin Gao D.A.B.M.G., F.A.C.M.G., FACMG, M.D., Ph.D. Chief Scientific Officer & Laboratory Director
Ms. Natalie Prescott VP of Legal & Deputy Gen. Counsel
Ms. Doreen Ng VP of Operations & Compliance and GM of Houston Office
Mr. Jakub Sram VP of Bus. Devel. & Sales
Ms. Ellen Tsui VP of HR
Mr. Brandon Perthuis Chief Commercial Officer
Dr. Lawrence M. Weiss M.D. Chief Medical Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 7.9365
Trailing PE: 3.6295
Price-to-Book MRQ: 0.7978
Price-to-Sales TTM: 1.1613
IPO Date: 2016-09-29
Fiscal Year End: December
Full Time Employees: 645
Back to stocks